mirna expression profiling microarray (Arraystar inc)
Structured Review
Mirna Expression Profiling Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+assay/mirna+expression+microarray/pm40646708-60-27-26
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Hybridization:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Expressing:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Stripping Membranes:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Control:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Construct:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Quantitative RT-PCR:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Comparison:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Transformation Assay:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Protein-Protein interactions:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Transfection:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the Western Blot:Article Title: Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma Article Snippet: The microarray hybridization was performed according to the manufacturer’s standard protocols (Agilent Technology, Shanghai, China) including purifying RNA, transcribing into fluorescent cDNA, and then hybridizing onto the |

